Pilot test of Consensus Reporting Items for Studies in Primary care (CRISP).

Prim Health Care Res Dev

School of Primary and Allied Health Care, Monash University, Melbourne, VIC, Australia.

Published: December 2023

The Consensus Reporting Items for Studies in Primary care (CRISP) provides a new research reporting guideline to meet the needs of the producers and users of primary care (PC) research. Developed through an iterative program of research, including investigators, practicing clinicians, patients, community representatives, and educators, the CRISP Checklist guides PC researchers across the spectrum of research methods, study designs, and topics. This pilot test included a variety of team members using the CRISP Checklist for writing, revising, and reviewing PC research reports. All or most of the 15 participants reported that the checklist was easy to use, improved research reports, and should be recommended by PC research journals. The checklist is adaptable to different study types; not all items apply to all reports. The CRISP Checklist can help meet the needs of PC research when used in parallel with existing guidelines that focus on specific methods and limited topics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790722PMC
http://dx.doi.org/10.1017/S1463423623000634DOI Listing

Publication Analysis

Top Keywords

primary care
12
crisp checklist
12
pilot test
8
consensus reporting
8
reporting items
8
items studies
8
studies primary
8
care crisp
8
crisp
5
checklist
5

Similar Publications

Importance: During buprenorphine treatment for opioid use disorder (OUD), risk factors for opioid relapse or treatment dropout include comorbid substance use disorder, anxiety, or residual opioid craving. There is a need for a well-powered trial to evaluate virtually delivered groups, including both mindfulness and evidence-based approaches, to address these comorbidities during buprenorphine treatment.

Objective: To compare the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) vs active control among adults receiving buprenorphine for OUD.

View Article and Find Full Text PDF

Importance: Timely access to care is a key metric for health care systems and is particularly important in conditions that acutely worsen with delays in care, including surgical emergencies. However, the association between travel time to emergency care and risk for complex presentation is poorly understood.

Objective: To evaluate the impact of travel time on disease complexity at presentation among people with emergency general surgery conditions and to evaluate whether travel time was associated with clinical outcomes and measures of increased health resource utilization.

View Article and Find Full Text PDF

Purpose: Mesothelin (MSLN) is highly expressed in high grade serous/ endometrioid ovarian cancers (HGOC). Anetumab ravtansine (AR) is an antibody drug conjugate directed at MSLN antigen with a tubulin polymerization inhibitor. We assessed safety, activity and pharmacokinetics of the combination AR/bevacizumab (Bev) (ARB) versus weekly paclitaxel (wP)/Bev (PB) in patients with platinum resistant/refractory HGOC (prrHGOC).

View Article and Find Full Text PDF

Importance: Spontaneous reports have indicated that montelukast increases the risk of neuropsychiatric adverse events, and the US Food and Drug Administration added a boxed warning about these risks in 2020. However, the potential mechanism is not well understood, and the observational evidence is scarce, particularly in children.

Objective: To assess the potential association between the use of montelukast and the risk of neuropsychiatric adverse events in children and adolescents.

View Article and Find Full Text PDF

Importance: Trials have not demonstrated superiority of alteplase or tenecteplase vs standard care in patients with mild stroke and have raised safety concerns. Prourokinase is an alternative fibrinolytic that may have a favorable safety profile, and the benefit-risk profile of prourokinase in mild stroke is unknown.

Objective: To investigate the efficacy and safety of prourokinase in mild ischemic stroke within 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!